Table 2. Baseline characteristics of different groups based on mean platelet volume values.
| High MPV (> 9.0 fl) (n = 305) | Medium MPV (7.9-9.0 fl) (n = 517) | Low MPV (< 7.9 fl) (n = 272) | p value | |
| Age (y/o) | 70 ± 14 | 69 ± 13 | 68 ± 13 | 0.025 |
| Sex (male) | 212 (69.5) | 370 (71.6) | 196 (72.1) | 0.493 |
| Smoking | 89 (29.2) | 145 (28.0) | 80 (29.4) | 0.997 |
| DM | 182 (59.7) | 263 (50.9) | 117 (43) | < 0.001 |
| HTN | 224 (73.4) | 353 (68.3) | 170 (62.5) | 0.005 |
| Old stroke | 39 (12.8) | 67 (13.0) | 16 (5.9) | 0.011 |
| DL | 158 (51.8) | 278 (53.8) | 148 (54.4) | 0.518 |
| CKD | 150 (49.2) | 220 (42.6) | 88 (32.4) | < 0.001 |
| Cr (mg/dL) | 2.18 ± 2.35 | 2.17 ± 2.57 | 2.02 ± 2.51 | 0.447 |
| HbA1C (%) | 7.0 ± 1.7 | 6.7 ± 1.7 | 6.4 ± 1.3 | < 0.001 |
| LDL (mg/dL) | 111 ± 43 | 111 ± 42 | 114 ± 38 | 0.389 |
| CRP (mg/L) | 68.5 ± 68.9 | 58.9 ± 71.7 | 46.2 ± 53.2 | 0.062 |
| ACS | 0.421 | |||
| STEMI | 83 (27.2) | 136 (26.3) | 78 (28.7) | |
| NSTEMI | 143 (46.9) | 238 (46.0) | 106 (39) | |
| UA | 79 (25.9) | 143 (27.7) | 88 (32.4) | |
| P2Y12 inhibitor | 0.409 | |||
| Clopidogrel | 265 (86.9) | 405 (78.3) | 226 (83.1) | |
| Ticagrelor | 29 (9.5) | 41 (7.9) | 36 (13.2) | |
| ACEi/ARB use | 182 (59.7) | 259 (50.1) | 181 (66.5) | 0.135 |
| Beta blocker use | 174 (57.0) | 266 (51.5) | 164 (60.3) | 0.491 |
| Statin use | 186 (61.0) | 299 (57.8) | 188 (69.1) | 0.056 |
Data are presented as mean ± SD or N (%).
ACEi/ARB, angiotensin-converting-enzyme inhibitor/angiotensin II receptor blockers; ACS, acute coronary syndrome; CKD, chronic kidney disease; Cr, creatinine; CRP, C-reactive protein; DL, dyslipidemia; DM, diabetes mellitus; HTN, hypertension; LDL, low-density lipoprotein; MPV, mean platelet volume; NSTEMI, non-ST elevation myocardial infarction; SD, standard deviation; STEMI, ST elevation myocardial infarction; UA, unstable angina.